Junior Members Forum by unknown
©  The Ulster Medical Society, 2006.
Junior Members Forum 95
www.ums.ac.uk



























of  melanoma  cells  to  the  invasive  phenotype  are  poorly 
understood. 
Methods:  In  this  study,  B16-F1  melanoma  cells  will  be 
transfected  into  a  gene  construct  that  may  influence  cell 
invasion. Expression of this gene and its coregulators will 
be assessed by immumohistochemistry in human archival 
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Objective:  Mutations  of  the  RET  proto-oncogene  are 
































outpatients  between  1947  and  the  1980s,  was  linked  to 
the  Northern  Ireland  Research  and  Statistics  Agency  to 
identify  those  who  had  died  and  their  death  certificate 
documentation.
Results:  Of 1919 cases on the registry (766 males, 1153 
females), 1393 had died, with death certificate data available 
in 1354 cases, 325 were alive and resident in Northern Ireland 
and 201 were untraceable.  Mean age at onset was 31.16 years 
and mean age at death 63.65 years. Median survival time was 
35 years, with no significant difference between genders, with 
age of onset or decade of onset. Standardized Mortality Ratios 
were 1.89 for males (CI 1.73-2.06) and 2.75 for females (CI 
2.56-2.95). Multiple sclerosis was documented as the cause 
of death (Part I) in 27%, as a contributing factor (Part II) in 
44% and not at all in 29% of death certificates. 
Conclusions:  Multiple sclerosis is associated with an elevated 
risk of death with an overall standardized mortality ratio of 
2.32. Median survival time was 35 years with no significant 
difference between genders or with age of onset or decade 
of onset. Death certificates produce unreliable estimates of 
mortality rates. In isolation, they underestimate the number of 
cases and the mean age at death in multiple sclerosis.